Last reviewed · How we verify
Experimental for steroids and antifungals
This experimental agent combines steroid and antifungal properties to modulate immune response while providing antifungal activity.
This experimental agent combines steroid and antifungal properties to modulate immune response while providing antifungal activity. Used for Fungal infections in immunocompromised patients (investigational).
At a glance
| Generic name | Experimental for steroids and antifungals |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease / Immunology |
| Phase | Phase 3 |
Mechanism of action
The drug is designed to address conditions requiring both immunosuppressive/anti-inflammatory effects (via steroid mechanism) and antifungal activity. This dual mechanism may be particularly useful in treating fungal infections in immunocompromised patients or conditions where both steroid and antifungal effects are therapeutically beneficial.
Approved indications
- Fungal infections in immunocompromised patients (investigational)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: